nodes	percent_of_prediction	percent_of_DWPC	metapath
Equilin—SHBG—hindlimb—amyotrophic lateral sclerosis	0.192	0.233	CbGeAlD
Equilin—HSD17B1—nervous system—amyotrophic lateral sclerosis	0.156	0.189	CbGeAlD
Equilin—HSD17B1—central nervous system—amyotrophic lateral sclerosis	0.15	0.182	CbGeAlD
Equilin—HSD17B1—brain—amyotrophic lateral sclerosis	0.119	0.144	CbGeAlD
Equilin—SHBG—hindbrain—amyotrophic lateral sclerosis	0.0875	0.106	CbGeAlD
Equilin—SHBG—brainstem—amyotrophic lateral sclerosis	0.0501	0.0608	CbGeAlD
Equilin—HSD17B1—Diseases associated with visual transduction—PLB1—amyotrophic lateral sclerosis	0.0257	0.147	CbGpPWpGaD
Equilin—SHBG—central nervous system—amyotrophic lateral sclerosis	0.0253	0.0307	CbGeAlD
Equilin—SHBG—cerebellum—amyotrophic lateral sclerosis	0.0247	0.03	CbGeAlD
Equilin—SHBG—brain—amyotrophic lateral sclerosis	0.0201	0.0243	CbGeAlD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.0112	0.0641	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.0103	0.0586	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00954	0.0545	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00897	0.0512	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—APOE—amyotrophic lateral sclerosis	0.00793	0.0453	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00615	0.0351	CbGpPWpGaD
Equilin—HSD17B1—Disease—TPK1—amyotrophic lateral sclerosis	0.00597	0.0341	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.005	0.0285	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.005	0.0285	CbGpPWpGaD
Equilin—HSD17B1—Disease—VTA1—amyotrophic lateral sclerosis	0.00477	0.0272	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00466	0.0266	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00457	0.0261	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00425	0.0243	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.004	0.0228	CbGpPWpGaD
Equilin—HSD17B1—Disease—CHMP2B—amyotrophic lateral sclerosis	0.00362	0.0206	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—DAO—amyotrophic lateral sclerosis	0.00361	0.0206	CbGpPWpGaD
Equilin—HSD17B1—Disease—PLB1—amyotrophic lateral sclerosis	0.00327	0.0187	CbGpPWpGaD
Equilin—HSD17B1—Disease—VCP—amyotrophic lateral sclerosis	0.00291	0.0166	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00274	0.0156	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSR—amyotrophic lateral sclerosis	0.00253	0.0144	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.0023	0.0131	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.00229	0.0131	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00215	0.0123	CbGpPWpGaD
Equilin—HSD17B1—Disease—CST3—amyotrophic lateral sclerosis	0.00209	0.0119	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00208	0.0118	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00204	0.0117	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00198	0.0113	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.00189	0.0108	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00176	0.01	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00174	0.00991	CbGpPWpGaD
Equilin—HSD17B1—Disease—CASP9—amyotrophic lateral sclerosis	0.00152	0.00868	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERBB4—amyotrophic lateral sclerosis	0.0013	0.00743	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.0013	0.00741	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.00119	0.00681	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00112	0.00638	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00112	0.00637	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00107	0.00608	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00102	0.00585	CbGpPWpGaD
Equilin—HSD17B1—Disease—APOE—amyotrophic lateral sclerosis	0.00101	0.00575	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000912	0.0052	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000857	0.00489	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000843	0.00481	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000757	0.00432	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000705	0.00403	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTGS2—amyotrophic lateral sclerosis	0.00069	0.00394	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000583	0.00333	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000578	0.0033	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000449	0.00256	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000424	0.00242	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000381	0.00217	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.000288	0.00164	CbGpPWpGaD
